This study assessed the safety and efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) and…
Category: Studies
A Phase 2 Study of BIT225, an Human Immunodeficiency Virus-1 (HIV-1) Vpu Inhibitor, in Treatment Naive HIV 1 Infected Individuals Commencing Dolutegravir-based Combination Antiretroviral Therapy (cART): Evaluation of Safety, Efficacy and Inflammatory and Immune Activation Markers
The proposed study will determine the potential efficacy and safety of a first-in-class HIV-1 Vpu inhibitor,…
A Phase 1b, Open-label study to Evaluate the PK, Safety and Efficacy of B/F/TAF in HIV-1 infected, Virologically Suppressed, Pregnant Women in their Second and Third Trimesters
The primary objective of this study is to evaluate the steady state pharmacokinetics of bictegravir (BIC)…
Substance use, Stigma, Depression and Disability among Adults with HIV in Asia
This cross sectional study is conducted among adults living with HIV receiving care at TAHOD study…
An Open-label, Single Arm Study to Evaluate the Week 48 Efficacy and Safety of a Two-drug Regimen of Dolutegravir/Lamivudine (DTG/3TC) as a Fixed Dose Combination (FDC), in Antiretroviral Therapy (ART)-Naive HIV-1-infected Adolescents, ≥ 12 to < 18 Years of Age Who Weigh at Least 25 kg
This is a Phase IIIb, single-arm, open-label, multi-center assessment of DTG/3TC in approximately 30 HIV-1 infected,…
Coronavirus in HIV Evaluation of Outcomes in Resource Limited Settings
COHIVE is an observational cohort study nested within four parent open label randomised clinical trials of…
A Phase 2/3 Study to Evaluate the Safety and Efficacy of Long Acting Capsid Inhibitor GS‑6207 in Combination with an Optimized Background Regimen in Heavily Treatment Experienced People Living with HIV-1 Infection with Multidrug Resistance
The primary objective of this study is to evaluate the antiviral activity of lenacapavir (formerly GS-6207)…
Effect of Antiretroviral Treatment Initiated During Acute HIV-1 Infection on Measures of HIV-1 Persistence and on HIV-1-Specific Immune Responses
The study is being done to: start ART early in those recently or acutely infected with…
Identification of Biomarkers to Predict Time to Plasma HIV RNA Rebound and Post-Treatment Viral Control during an Intensively Monitored Antiretroviral Pause (IMAP)
The purpose of this study is to collect information about what happens when people pause, or…
Plan for obtaining human biological samples at non-U.S. clinical research sites for currently unspecified genetic analyses
This is a study to collect blood and saliva samples from former and current participants in…
